Efficacy of ARNIs on hard renal outcomes in heart failure with and without chronic kidney disease: when endpoint definition matters—an updated meta-analysis
ESC Heart Failure · 04.07.2026 · 13 (4)
DOI: 10.1093/eschf/xvag148 ↗Kurz gefasst
Metaanalyse in der Zeitschrift ESC Heart Failure, online erschienen am 05.06.2026. Verfasst von Giuseppe Cianciolo und 8 weiteren Autor:innen. Beteiligte Einrichtung: Nephrology, Dialysis and Kidney Transplant Unit, IRCCS Azienda Ospedaliero-Universitaria di Bologna, Bologna, Italy. Hauptthemen laut MEDLINE: Heart Failure, Renal Insufficiency, Chronic, Aminobutyrates, Glomerular Filtration Rate. Die Arbeit nennt 29 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Themen: Herzinsuffizienz
Abstract (Originalsprache)
Background
The renal effects of sacubitril/valsartan (Sac/Val) in heart failure (HF) remain incompletely defined, partly because kidney outcomes in pivotal HF trials have been variably prespecified and heterogeneously defined. We performed an updated systematic review and meta-analysis to assess whether the apparent renal signal of Sac/Val varies according to endpoint definition.
Methods
This updated systematic review was conducted in accordance with PRISMA 2020. Building on the pre-existing evidence base from prior meta-analyses, we performed an updated search of PubMed and Web of Science. Randomized controlled trials (RCTs) and observational comparative studies in adults with HF comparing Sac/Val with angiotensin-converting enzyme inhibitors, angiotensin receptor blockers, or standard care were included if renal outcome data were extractable. Renal outcomes were analysed using a hierarchical cross-endpoint approach, including sustained ≥50% estimated glomerular filtration rate (eGFR) decline, end-stage kidney disease (ESKD), composite kidney outcomes, and annualized eGFR decline. Random-effects meta-analysis was performed, with Hartung-Knapp and RCT-only sensitivity analyses.
Results
Overall, 13 study-level reports comprising 34 969 patients were included. Sac/Val was associated with a lower risk of sustained 50% eGFR decline (risk ratio [RR] 0.68, 95% confidence interval [CI] 0.57–0.82) and composite kidney outcome (RR 0.70, 95% CI 0.58–0.84), with the composite endpoint showing the most robust and consistent signal, including in RCT-only analyses. By contrast, the association for ESKD alone was directionally favourable but not statistically significant (RR 0.80, 95% CI 0.64–1.00). Sac/Val was also associated with a slower annualized eGFR decline (MD 0.52 mL/min/1.73 m2/year, 95% CI 0.35–0.69).
Conclusions
The renal signal associated with Sac/Val in HF appeared at least partly dependent on endpoint definition. Composite kidney outcomes may best capture its potential nephroprotective effect, with sustained 50% eGFR decline showing a consistent pattern, whereas isolated ESKD remains inconclusive. These findings support a potential nephroprotective role of ARNIs but future research are needed.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Nephrology, Dialysis and Kidney Transplant Unit, IRCCS Azienda Ospedaliero-Universitaria di Bologna, Bologna, Italy.
- Department of Medical and Surgical Science (DIMEC), Alma Mater Studiorum-University of Bologna, Bologna, Italy.
- Nephrology and Dialysis Unit, ASL TO4, Turin, Italy.
- Department of Medical and Surgical Sciences, University of Foggia, Foggia, Italy.
- Department of Cardiovascular Medicine, Ospedale V Fazzi, ASL Lecce, Lecce, Italy.
- Cardiology Unit, Azienda Ospedaliero-Universitaria di Ferrara, Cona, Ferrara, Italy.
ORCID-Profile: Daniele Vetrano, Massimo Iacoviello, Gaetano La Manna
Zitieren
APA
Cianciolo, G., Vetrano, D., Tomassetti, A., Tringali, E., Iacoviello, M., Marazia, S., Fucili, A., La Manna, G., & De Pascalis, A. (2026). Efficacy of ARNIs on hard renal outcomes in heart failure with and without chronic kidney disease: when endpoint definition matters—an updated meta-analysis. ESC Heart Failure, 13(4). https://doi.org/10.1093/eschf/xvag148
Vancouver
Cianciolo G, Vetrano D, Tomassetti A, Tringali E, Iacoviello M, Marazia S, et al. Efficacy of ARNIs on hard renal outcomes in heart failure with and without chronic kidney disease: when endpoint definition matters—an updated meta-analysis. ESC Heart Failure. 2026;13(4). doi:10.1093/eschf/xvag148
BibTeX
@article{Cianciolo2026,
author = {Cianciolo, Giuseppe and Vetrano, Daniele and Tomassetti, Alessandro and Tringali, Edoardo and Iacoviello, Massimo and Marazia, Stefania and Fucili, Alessandro and La Manna, Gaetano and De Pascalis, Antonio},
title = {Efficacy of ARNIs on hard renal outcomes in heart failure with and without chronic kidney disease: when endpoint definition matters—an updated meta-analysis},
journal = {ESC Heart Failure},
year = {2026},
volume = {13},
number = {4},
doi = {10.1093/eschf/xvag148}
}
EUVIMED